Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Case Study Life Sciences & Pharma Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company March 31, 2025 A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…
Published Articles Life Sciences & Pharma A Strategic Framework for Evaluating AI in Drug Discovery December 6, 2024
Published Articles Digital It’s time to go all-in on digital: Four key strategies of successful leaders November 7, 2024
Article Healthcare Services Healthcare Crossroads? The 2024 Election and What’s Really at Stake October 29, 2024
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024